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Background
Human herpesvirus-8 (HHV-8) infection is endemic in
Uganda and has an estimated 36%-60% seroprevalence.
This virus is in the oropharynx and peripheral blood of
Ugandans with Kaposi’s sarcoma, and viremia is
increased in those with HIV-1. While Kaposi’ss a r c o m a
is widely recognized as both endemic and with HIV epi-
demic, HHV-8 associated lymphoproliferative disorders
have not been previously reported in Uganda. Evidence
for these disorders was sought in lymphoma surveys
conducted by sub-Saharan African Lymphoma Consor-
tium (SSALC) consortium members in Uganda.
Materials and methods
Samples of 456 malignant lymphoma and adenopathy
cases in formalin-fixed paraffin-embedded (FFPE) blocks
from the Uganda SSALC and the Uganda AIDS and
Cancer Specimen Resource (ACSR) were examined for
morphology and Lana-1 (immunohistochemical, IHC)
for diagnosis of HHV-8 lymphoproliferative disorders.
Samples were also tested (IHC and in situ hybridization,
ISH) using 20 monoclonal antibodies for common NHL
antigens, ISH for EBV-encoded RNA, and kappa/lambda
light chains (ISH, Ventana, Tucson).
Results
Many but not all of reported HHV-8-related prolifera-
tive disorders were identified in this sample population.
Those identified and remaining to be identified are
listed in Table 1.
Conclusions
HHV-8 proliferative disorders excluding Kaposi’s
sarcoma are present but generally not recognized by
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Table 1 Subtypes
Subtype N
Unicentric varieties Hyaline vascular variant 2
Castleman’s disease Multicentric varieties Plasma cell variant 1
Plasmablastic variant 1
Lymphocyte depleted 1
Plasmablastic lymphoma (HHV-8 negative and positive) 2
Primary effusion lymphoma
Peripheral T-cell lymphoma
Diffuse large B-cell lymphoma
Plasmacytic lymphoproliferative disorder 1
Total 8
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© 2010 Ayers et al; licensee BioMed Central Ltd.Ugandan clinicians and pathologists. Disorders are pre-
sent in Uganda, especially in HIV-positive patients, in
association with the high infection rates of both HIV-1
and HHV-8. Recognition is important because HHV-8
infection in HIV-1-positive patients associates with poor
prognosis. Familiarity with the clinical presentation and
tissue morphology of these disorders will likely result in
recognition of the full range of reported HHV-8 prolif-
erative complications. HHV-8-related lymphoma has
increased prevalence in the HIV-1 infected. It arises and
progresses in the face of highly active antiretroviral ther-
apy immune reconstitution, making recognition of these
disorders critical to patient care. We participate in the
Sub-Saharan Africa Lymphoma Consortium [http://
www.ssalc.org] to expand the understanding of HIV/
AIDS-related malignancies and viral proliferative dis-
orders in this region of the world.
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